Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation.
Richard G JungOmar Abdel-RazekPietro Di SantoTaylor GillmoreCameron StottsDwipen MakwanaJoelle SorianoRobert MorelandLouis Verreault-JulienCheng Yee GohSimon ParlowCaleb SypkesDaniel F RamirezMouhannad SadekVincent ChanHadi ToegTrevor SimardMichael P V FroeschlMarino LabinazBenjamin HibbertPublished in: Open heart (2022)
Preprocedural and new-onset AF following revascularisation remains highly predictive 1-year MACE. AF should be considered in addition to traditional risk factors for adverse outcomes following revascularisation.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- coronary artery disease
- direct oral anticoagulants
- coronary artery
- heart failure
- percutaneous coronary intervention
- left ventricular
- adverse drug
- emergency department
- acute coronary syndrome
- transcatheter aortic valve replacement